A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
Xiaoniu Miao, Yingda Xu, Tiong Kit Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuefeng Zou, William James(University of Oxford), Liping Wan, Wenchao Jiang, Yi-Feng Xu, Yao Yan, Alain Townsend(Chinese Academy of Medical Sciences & Peking Union Medical College), Weihui Fu, Liandi Chen, Michael L. Knight(University of Oxford), Pramila Rijal(Chinese Academy of Medical Sciences & Peking Union Medical College), Javier Gilbert‐Jaramillo(University of Oxford), Tuling Pang, Suki Man-Yan Lee(HKU-Pasteur Research Pole), Xuedong Song, Xi Huang(Sun Yat-sen University), Yongzhou Tang, Joanne Sun, Xiaolin Liu(Hebei Medical University), Chao Wang(The University of Texas MD Anderson Cancer Center), Cheng Chen, Yi Luo, Andy Tsun(University of Cambridge), Wei Gao(National Cancer Institute), Fan Wu(Fudan University), Zhijun Yuan
Cited by 35
Related Papers
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Neurological manifestations of dengue infection
|The Lancet|2000|637
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337